Refine by
Patient Comfort Articles & Analysis: Older
737 news found
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, announced today that Tennessee Oncology, one of the United States’ largest community-based cancer care specialists that treats nearly half of Tennessee’s cancer patients across 35 clinics, has expanded its relationship with SOPHiA GENETICS to advance its cancer research. ...
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, today announced the next step in the partnership between the Company and Genomenon, a leading genomic intelligence company, to support better, data-driven outcomes in the rare disease and oncology fields. The two companies have expanded the integration of Genomenon’s Mastermind® Genomic ...
The medical device industry is undergoing a transformative period marked by groundbreaking innovations and advanced materials. As healthcare continues to evolve, the need for devices that enhance patient outcomes while ensuring safety and reliability is more critical than ever. Among the various materials used in medical device design, polytetrafluoroethylene (PTFE tubing) has emerged as a ...
International Infection Prevention Week (IIPW) has been championed by the Association for Professionals in Infection Control and Epidemiology since 1986. The annual event highlights the importance of infection prevention professionals and their efforts and control practices. These are crucial tasks as the Centers for Disease Control and Prevention (CDC) reports that on any given day, about 1 in ...
A Centers for Disease Control and Prevention (CDC) report published on October 3, 2024, linked Burkholderia multivorans infections to ice machines in multiple healthcare facilities in the western United States. This post summarizes key findings, implications, and recommended practices for healthcare providers to ensure patient ...
The Association for Professionals in Infection Control and Epidemiology (APIC) has championed International Infection Prevention Week since 1986. For 2024, the annual event is taking place from October 13th to the 19th. International Infection Prevention Week highlights the importance of infection prevention professionals and their efforts and control practices. These are crucial tasks as the ...
Biopharma PEG, a key provider of premium polyethylene glycol (PEG) derivatives, is thrilled to announce a substantial expansion of its large-scale Good Manufacturing Practice (GMP) production capabilities. This strategic move is aimed at addressing the rising global demand for Lipid Nanoparticles (LNPs), which are vital for nucleic acid drug delivery, especially in mRNA-based therapies and ...
The IAQ Video Network and Cochrane & Associates announced the release of their latest educational video today. Their newest production discusses International Infection Prevention Week (IIPW). “For 2024, IIPW is taking place from October 13th to the 19th,” said Paul Cochrane, President of Cochrane & Associates and the IAQ Video Network. “Infection prevention ...
MedSource Labs understands the critical importance of ensuring clinician access to high-quality medical supplies, as it directly impacts patient care and outcomes. In the face of global challenges, such as supply chain disruptions due to a spike in geopolitical conflicts, the time it takes to move products by sea and air has vastly increased. The costs related to the longer transit time has ...
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, will unveil new research at the European Society for Medical Oncology (ESMO) 2024. The study, conducted in collaboration with AstraZeneca, leverages advanced AI-driven techniques to identify subgroups of stage IV non-small cell lung cancer (NSCLC) patients who could most benefit from ...
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today launched the new generation of the SOPHiA DDM™ Platform. The new-gen SOPHiA DDM™ Platform offers a new architecture designed to more efficiently compute large amounts of data at-scale, while elevating customer experience with integrated access to multimodal ...
Listen to Synaptive’s President and Co-Founder, Cameron Piron on the Epicor weekly episode of Manufacturing the Future with Kerrie Jordan. Cameron shares invaluable leadership and entrepreneurial insights, reflecting on the journey of founding and growing Synaptive globally, how he leverages artificial intelligence to enhance surgical outcomes and streamline medical procedures, and the ...
US-based MedSource Labs and Sydney’s Medilogic enter into an exclusive, strategic partnership in the peripheral safety IV market with the announcement of Logiflow Exactus and Logiflow Exactus Shield with Blood Control IV Catheters with active blood control check valve technology in ...
In a significant development for the cosmetics industry, CD Formulation has introduced an extensive array of cosmetic ingredients, making waves with its new offerings of moisturizers, propellant cosmetic chemicals, and emulsifiers. This latest product launch aims to provide formulators and manufacturers with high-quality, versatile ingredients to enhance the efficacy and appeal of cosmetic ...
Tempus, a leader in artificial intelligence and precision medicine, announced new testing solutions to help physicians identify patients with HER2 or FOLR1 expressing tumors, which may make such patients eligible for targeted therapies such as antibody–drug conjugates (ADCs). HER2 and FOLR1 testing by immunohistochemistry (IHC) is now available for all solid tumor cancers as an ...
ByTempus
Tempus, a leader in artificial intelligence and precision medicine, today announces an expansion of its collaboration with AstraZeneca, which leverages Tempus Next to arm physicians with technology that supports the delivery of guideline-directed biomarker testing for patients with non-small cell lung cancer (NSCLC). The magnitude and frequency of updates to oncology guidelines each year make it ...
ByTempus
Tempus, a leader in artificial intelligence and precision medicine, today announced the clinical launch of its minimal residual disease (MRD) test portfolio, including Tempus’ xM test and the xM (NeXT Personal® Dx) test by Personalis. The portfolio features both a tumor-naïve assay and a tumor-informed assay that are designed to help detect residual disease or early cancer ...
ByTempus
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced European CE Mark approval of the AlphaVac F1885 System for the non-surgical removal of thrombi or emboli from the pulmonary arteries and for ...
MedSource Labs Moves the Needle in the Peripheral Safety IV Market With the announcement of ClearSafe Comfort® and TrueSafe Comfort® Blood Control IV Catheters with groundbreaking active check valve ...
Dave Kunelius, President of MedSource Labs, recently addressed the Honorable Katherine Tai, United States Trade Representative, as part of an ongoing dialogue with local and national policymakers concerning challenges in the medical supply chain. In his communication dated April 19, 2024, Kunelius emphasized MedSource Labs’ role in manufacturing essential medical devices, such as IV ...